ACUTE MYELOID LEUKAEMIA (AML)
Clinical trials for ACUTE MYELOID LEUKAEMIA (AML) explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKAEMIA (AML) trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKAEMIA (AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to wipe out lingering leukemia cells
Disease control Not yet recruitingThis study is testing whether combining two existing drugs, sorafenib and venetoclax, can help patients with acute myeloid leukemia (AML) who still have tiny, hard-to-detect amounts of cancer left after their first treatment. The goal is to use this drug combination as a 'pre-emp…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Phase: PHASE2, PHASE3 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Apr 02, 2026 02:40 UTC
-
Blood test could be key to picking winning leukemia treatment
Disease control Not yet recruitingThis study is testing whether a new blood test can help doctors choose the most effective chemotherapy for adults newly diagnosed with acute myeloid leukemia (AML). About 112 patients will receive one of two standard chemotherapy types, and the blood test will check for tiny amou…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Phase: PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Cancer patients get chance to continue promising treatment
Disease control Not yet recruitingThis study allows cancer patients who are already benefiting from RVU120 treatment in a previous trial to continue receiving it. It aims to monitor safety and track how long patients can stay on the treatment. Only 10 participants who show continued benefit and cannot access stan…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Phase: PHASE2 • Sponsor: Ryvu Therapeutics SA • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC